Interestingly, treatment with IL-6 receptor blocking antibodies inhibits IL-6 receptor expression as well as STAT3 phosphorylation and increases the frequency of Treg cells in the peripheral blood of RA patients (Fig. 3b and Supplementary Fig. S6, S7). The gene discussed is STAT3; the disease is rheumatoid arthritis.